RXRG and retinoblastoma: As indicated by the upregulation of cone-specific transcription factor RXRG [36], sunitinib induced cone differentiation in MYCN-amplified RB170 which has been classified as aggressive RB exhibiting poor differentiation and dedifferentiated cone states (subtype 2) [23].